AI Co-Scientist Uncovers Novel EGFR Inhibitors for Drug-Resistant Lung Cancer

The Challenge of Drug Resistance in Lung CancerThe bigger takeaway is simple: Non-small cell lung cancer (NSCLC) patients often face a critical hurdle: the